SAGP Strategas Global Policy Opportunities ETF
ETF on NYSE (US) · Actively managed · Listing
Most notable sale · Yum! Brands, Inc.
Yum! Brands, Inc. sold out
Shares went from 9,229 to 0 ($1.43M → $0). Was 2.0% of the Mar 31, 2026 portfolio.
Most notable buy · Ciena Corporation
New position in Ciena Corporation
3,299 shares worth $1.62M. Now 2.2% of the portfolio.
Largest holding: Teradyne, Inc., cut 14%, 4,126 shares ($2.00M).
| Current positions Top 10 | % of book |
|---|---|
| Teradyne, Inc. TER $2.00M · −14% sh | 2.7% |
| Axon Enterprise, Inc. AXON $1.80M · +25% sh | 2.4% |
| Stanley Black & Decker, Inc. SWK $1.74M · −1% sh | 2.3% |
| Ciena Corporation CIEN $1.62M · NEW | 2.2% |
| DaVita Inc. DVA $1.61M · −26% sh | 2.1% |
| Chipotle Mexican Grill, Inc. CMG $1.60M · NEW | 2.1% |
| Biogen Inc. BIIB $1.60M · NEW | 2.1% |
| A.O. Smith Corporation AOS $1.57M · +23% sh | 2.1% |
| Humana Inc. HUM $1.56M · NEW | 2.1% |
| Incyte Corporation INCY $1.54M · −10% sh | 2.1% |
Slices are % of holdings value. Changes ("sh" shares, "units" other holdings) are in the quantity held against Mar 31, 2026.
| Sectors | % of holdings value |
|---|---|
| Healthcare | 26.8% |
| Industrials | 23.9% |
| Technology | 12.4% |
| Communication Services | 8.5% |
| Financial Services | 5.4% |
| Consumer Defensive | 4.5% |
| Consumer Cyclical | 4.2% |
| Basic Materials | 4.0% |
| Other (1) | 1.7% |
| Unclassified | 8.6% |
| Industries | % of holdings value |
|---|---|
| Aerospace & Defense | 10.6% |
| Biotechnology | 9.4% |
| Software - Application | 6.4% |
| Medical Devices | 5.7% |
| Internet Content & Information | 4.6% |
| Diagnostics & Research | 3.5% |
| Tobacco | 3.5% |
| Other (36) | 47.7% |
| Unclassified | 8.6% |
| Initiations 21 | Value |
|---|---|
| Ciena Corporation CIEN 2.2% of portfolio | $1.62M |
| Chipotle Mexican Grill, Inc. CMG 2.1% of portfolio | $1.60M |
| Biogen Inc. BIIB 2.1% of portfolio | $1.60M |
| Humana Inc. HUM 2.1% of portfolio | $1.56M |
| Labcorp Holdings Inc. LH 2.0% of portfolio | $1.49M |
| Gilead Sciences, Inc. GILD 2.0% of portfolio | $1.49M |
| Insulet Corporation PODD 1.9% of portfolio | $1.45M |
| CF Industries Holdings, Inc. CF 1.9% of portfolio | $1.42M |
| Sezzle Inc. SEZL 0.3% of portfolio | $212K |
| Remitly Global, Inc. RELY 0.2% of portfolio | $186K |
| Reynolds Consumer Products Inc. REYN 0.2% of portfolio | $171K |
| Solstice Advanced Materials Inc. SOLS 0.2% of portfolio | $170K |
| Increases 38 | Change |
|---|---|
| Huntington Ingalls Industries, Inc. HII $1.32M → $1.39M | +43% |
| CSL LIMITED $1.14M → $1.32M | +40% |
| Axon Enterprise, Inc. AXON $1.09M → $1.80M | +25% |
| Leidos Holdings, Inc. LDOS $1.29M → $1.21M | +42% |
| Eisai Co., Ltd. $1.20M → $1.30M | +31% |
| A.O. Smith Corporation AOS $1.34M → $1.57M | +23% |
| Biomerieux BIM $1.16M → $1.16M | +34% |
| Lockheed Martin Corporation LMT $1.35M → $1.39M | +22% |
| Fair Isaac Corporation FICO $1.06M → $1.40M | +19% |
| SAAB SAAB-B $1.16M → $1.13M | +21% |
| Cameco Corporation CCJ $1.16M → $1.28M | +18% |
| Palantir Technologies Inc. PLTR $1.40M → $1.28M | +15% |
| Reductions 41 | Change |
|---|---|
| DaVita Inc. DVA $1.50M → $1.61M | −26% |
| InterContinental Hotels Group PLC IHG $1.21M → $1.27M | −20% |
| Teradyne, Inc. TER $1.42M → $2.00M | −14% |
| VeriSign, Inc. VRSN $1.52M → $1.25M | −19% |
| Fox Corporation FOXA $1.46M → $1.10M | −15% |
| Novo Nordisk A/S NOVOB $1.12M → $1.32M | −13% |
| Incyte Corporation INCY $1.42M → $1.54M | −10% |
| Altria Group, Inc. MO $1.44M → $1.41M | −10% |
| Hims & Hers Health, Inc. HIMS $199K → $186K | −44% |
| Kyowa Kirin Co., Ltd. $1.43M → $1.28M | −9% |
| DexCom, Inc. DXCM $1.30M → $1.29M | −7% |
| Pitney Bowes Inc. PBI $154K → $155K | −37% |
| Terminations 22 | Change |
|---|---|
| Yum! Brands, Inc. YUM was $1.43M | −100% |
| Match Group, Inc. MTCH was $1.43M | −100% |
| eBay Inc. EBAY was $1.43M | −100% |
| Vertex Pharmaceuticals Incorporated VRTX was $1.42M | −100% |
| Honeywell International Inc. HON was $1.39M | −100% |
| Northrop Grumman Corporation NOC was $1.35M | −100% |
| Equifax, Inc. EFX was $1.27M | −100% |
| Skydance Corporation PSKY was $1.12M | −100% |
| Core Natural Resources, Inc. CNR was $179K | −100% |
| Century Aluminum Company CENX was $166K | −100% |
| Ingevity Corporation NGVT was $161K | −100% |
| Bristow Group, Inc. VTOL was $160K | −100% |
The other 9 initiations
Glaukos Corporation ($170K), PTC Therapeutics, Inc. ($166K), Pacira BioSciences, Inc. ($162K), Indivior Pharmaceuticals, Inc. ($161K), Universal Technical Institute Inc ($161K), UL Solutions Inc. ($156K), KBR, Inc. ($151K), Gogo Inc. ($136K), Booz Allen Hamilton Holding Corporation ($117K)
The other 26 increases
Astellas Pharma Inc. (+11%), Smith & Nephew PLC (+10%), Universal Music Group N.V. (+8%), Beone Medicines Ltd. (+7%), Spotify Technology S.A. (+8%), Experian plc (+6%), Phibro Animal Health Corporation (+56%), General Dynamics Corporation (+4%), Textron Inc. (+3%), InterDigital, Inc. (+41%), Nexstar Media Group, Inc. (+44%), Smiths Group plc (+4%), Ferrovial SE (+2%), Maximus, Inc. (+26%), EQT (+2%), Arlo Technologies, Inc. (+14%), Fresenius Medical Care AG (+1%), Parsons Corporation (+14%), Sylvamo Corporation (+11%), Brookfield Asset Management Inc (+1%) and 6 more
The other 29 reductions
Canadian Pacific Kansas City Limited (−7%), Lattice Semiconductor Corporation (−32%), CoreCivic, Inc. (−32%), SolarEdge Technologies, Inc. (−32%), British American Tobacco p.l.c. (−6%), Lantheus Holdings, Inc. (−25%), Illumina, Inc. (−23%), LiveRamp Holdings, Inc. (−24%), Exelixis, Inc. (−23%), Covista Inc. (−23%), Harmony Biosciences Holdings, Inc. (−21%), Neurocrine Biosciences, Inc. (−21%), Etsy, Inc. (−19%), Polaris Inc. (−19%), Chemours Company (The) (−19%), Science Applications International Corporation (−20%), H&R Block, Inc. (−16%), Stanley Black & Decker, Inc. (−1%), Stride, Inc. (−15%), HealthEquity, Inc. (−12%) and 9 more
The other 10 terminations
SunCoke Energy, Inc. ($158K), Grand Canyon Education, Inc. ($157K), Koppers Holdings Inc. ($155K), Materion Corporation ($146K), Amneal Pharmaceuticals, Inc. ($145K), Hexcel Corporation ($138K), Myriad Genetics, Inc. ($133K), Kratos Defense & Security Solutions, Inc. ($125K), TransMedics Group, Inc. ($108K), BROWN BROTHERS HARRIMAN & CO. FX Forward Contract: USD/JPY SETTLE 2026-04-01 (−$29)
Source: the fund's quarterly portfolio reports to the SEC, the portfolio of Jun 30, 2026 (Form N-PORT) vs the portfolio of Mar 31, 2026 (Form N-PORT). Percent changes are changes in the quantity held (shares, or units for holdings that are not a listed equity); dollar values are as reported at each period end. Each column is ranked by the estimated dollar size of the trade: a new or closed position at its value, otherwise the change in shares at the position's own period-end price. Where shares and price per share moved by inverse whole multiples (a split), the earlier share count is restated. Cash and money-market lines are in the book and its value but are never counted as trades. Short positions are listed as such, at their (negative) printed value.
Objective
From the summary prospectus filed May 8, 2026.
The Strategas Global Policy Opportunities ETF (the "Global Policy Opportunities ETF" or the "Fund") seeks long-term capital appreciation.
Principal investment strategies
The Fund is an actively-managed exchange-traded fund ("ETF") that seeks to achieve its objective by investing principally in the common stocks of U.S. and non-U.S. companies interested in influencing public policy through their lobbying activity in Washington D.C. Strategas Asset Management, LLC (the "Adviser") considers lobbying a nontraditional and largely unrecognized factor in company analysis. By utilizing publicly available lobbying data in its portfolio selection methodology, the Adviser seeks to capitalize on what the Adviser perceives as a lack of consideration given to lobbying in traditional financial analysis and lobbying's potential to sway policy outcomes in companies' favor. The Adviser believes that successful lobbying activity can reduce costly regulatory and legislative harm to a company, impose such harm onto competitors, and/or result in beneficial legislative and regulatory decisions, and that each of these outcomes can have a positive impact on a company's financial performance and contribute to the long-term appreciation of a company's stock price. The Adviser uses publicly disclosed corporate lobbying data filed pursuant to the Lobbying Disclosure Act (the "LDA") as part of its investment process. The LDA is U.S. federal legislation that requires the disclosure of lobbying activities intended to influence the U.S. federal government. The Adviser uses LDA data to assess the degree to which companies included in the S&P 500, S&P 1000, and MSCI All Country World Indexes lobby the U.S. federal government, which the Adviser refers to as "lobbying intensity." The Adviser's methodology determines a company's lobbying intensity by taking into account the company's lobbying spend reported under the LDA and the company's size. The Adviser's methodology does not take into account the legislation on which a company lobbies or whether a company's lobbying efforts are successful. The Adviser selects securities for the Fund based on a company's lobbying intensity only and does not consider a company's traditional financial metrics when constructing the Fund's portfolio. After determining the lobbying intensity of companies in the investment universe, the Adviser determines a weighting and allocation strategy among non-U.S. large capitalization and U.S. large, medium and small capitalization companies based on the Adviser's asset allocation recommendations. The Adviser's recommendations reflect its tactical assessment of the balance of risks between large, medium, and small capitalization securities; U.S., international and emerging market issuers; and securities classified as value, core, or growth. The Adviser generally utilizes a thematic investing approach pursuant to which it overweights allocations to assets which it believes the current investment environment favors and underweights allocations to those which it believes the current investment environment 3 is less favorable. "Thematic" refers to the theses, trends or views that the Adviser believes are prevalent or likely to be prevalent in the market. The Adviser then selects companies with the highest lobbying intensity ratings based on the Adviser's weighting and allocation recommendations to construct a portfolio of generally 100 securities. The Adviser assesses lobbying intensity determinations quarterly in connection with quarterly LDA filings, which may lead to portfolio changes based off changes in reported lobbying activity. Other than quarterly purchases and sales, the Adviser may sell a security due to a change in asset allocation recommendations or an issuer's corporate action. Under normal circumstances, the Fund invests in at least three countries, including the U.S., and invests at least 40% of its total assets in securities of non-U.S. companies. If conditions are not favorable, the Fund will invest at least 30% of its total assets in securities of non-U.S. companies. The Fund considers a company to be a non-U.S.
Management and Contact
- Adviser
- Strategas Asset Management, LLC
- Sub-adviser
- Vident Asset Management
- Portfolio managers
-
The Fund is jointly and primarily managed by a team of the following professionals: Strategas Asset Management, LLC Dan Clifton, Portfolio Manager at Strategas Asset Management, LLC and Head of Policy Research at Strategas Securities, LLC, has served as a lead portfolio manager of the Fund since its inception in 2022.
Courtney Rosenberger Gelman, Analyst at Strategas Asset Management, LLC and Managing Director at Strategas Securities, LLC, has served as a lead portfolio manager of the Fund since its inception in 2022.
Nicholas Bohnsack, President and Chief Executive Officer at Strategas Asset Management, LLC and President and Chief Operating Officer at Strategas Securities, LLC, has served as a co-portfolio manager of the Fund since its inception in 2022.
Gerald Hendricks, Director & Senior Portfolio Analyst at Strategas Asset Management, LLC, has served as a co-portfolio manager of the Fund since its inception in 2022.
Vident Asset Management Rafael Zayas, CFA, Senior Vice President, Head of Portfolio Management and Trading of Vident Asset Management, has served as a portfolio manager of the Fund since its inception in 2022.
Austin Wen, CFA, Senior Portfolio Manager of Vident Asset Management has served as a portfolio manager of the Fund since its inception in 2022.
Devin Ryder, CFA, Senior Portfolio Manager of Vident Asset Management has served as a portfolio manager of the Fund since May 2026.
- Phone
- 855-457-3637
- [email protected]
- Website
- strategasetfs.com/sagp
Track Record as of Dec 31, 2025
Average annual total returns from the summary prospectus. Returns in percent; periods over a year are annualized.
| 1 Year | Since Inception | |
|---|---|---|
| Fund Returns Before Taxes | 22.55% | 9.92% |
| Fund Returns After Taxes on Distributions | 21.58% | 9.45% |
| Fund Returns After Taxes on Distributions and Sale of Fund Shares | 14.05% | 7.75% |
| MSCI All Country World Index (Net) (reflects no deduction for fees, expenses or taxes (except foreign withholding taxes)) | 22.34% | 11.40% |
Holdings as of Jun 30, 2026
The full portfolio as of the quarter end Jun 30, 2026, from the fund's report to the SEC (Form N-PORT, filed Aug 28, 2026), the newest we have: we do not read a daily file from this fund's website, or the filing is newer. Every line is listed: holdings we could identify link to their page, the rest (bonds, CLOs, loans, derivatives, securities we do not carry) are shown as filed, debt with its coupon and maturity; Shares is the principal amount for debt. Short positions are negative. Change is the share count against the filing of Mar 31, 2026.
100 lines, 94 linked, weights sum to 97.96% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| TERADYNE, INC. | US8807701029 | Equity | 4,126 | −661 | 2.61% | $ 1.996M |
| AXON ENTERPRISE, INC. | US05464C1018 | Equity | 3,203 | +639 | 2.34% | $ 1.796M |
| STANLEY BLACK & DECKER, INC. | US8545021011 | Equity | 18,510 | −271 | 2.27% | $ 1.742M |
| CIENA CORPORATION | US1717793095 | Equity | 3,299 | new +3,299 | 2.11% | $ 1.618M |
| DAVITA INC. | US23918K1088 | Equity | 7,223 | −2,524 | 2.10% | $ 1.607M |
| CHIPOTLE MEXICAN GRILL, INC. | US1696561059 | Equity | 47,137 | new +47,137 | 2.09% | $ 1.603M |
| BIOGEN INC. | US09062X1037 | Equity | 7,383 | new +7,383 | 2.08% | $ 1.595M |
| A. O. SMITH CORPORATION | US8318652091 | Equity | 25,059 | +4,753 | 2.05% | $ 1.572M |
| HUMANA INC. | US4448591028 | Equity | 3,935 | new +3,935 | 2.04% | $ 1.563M |
| INCYTE CORPORATION | US45337C1027 | Equity | 13,606 | −1,430 | 2.01% | $ 1.542M |
| LABCORP HOLDINGS INC. | US5049221055 | Equity | 5,338 | new +5,338 | 1.95% | $ 1.495M |
| GILEAD SCIENCES, INC. | US3755581036 | Equity | 11,803 | new +11,803 | 1.95% | $ 1.491M |
| GENERAL DYNAMICS CORPORATION | US3695501086 | Equity | 4,205 | +151 | 1.94% | $ 1.49M |
| INSULET CORPORATION | US45784P1012 | Equity | 9,515 | new +9,515 | 1.89% | $ 1.449M |
| TEXTRON INC. | US8832031012 | Equity | 15,701 | +530 | 1.88% | $ 1.44M |
| CF INDUSTRIES HOLDINGS, INC. | US1252691001 | Equity | 13,123 | new +13,123 | 1.85% | $ 1.421M |
| Altria Group, Inc. | US02209S1033 | Equity | 19,608 | −2,204 | 1.84% | $ 1.411M |
| FAIR ISAAC CORPORATION | US3032501047 | Equity | 1,175 | +184 | 1.83% | $ 1.404M |
| LOCKHEED MARTIN CORPORATION | US5398301094 | Equity | 2,731 | +497 | 1.82% | $ 1.391M |
| HUNTINGTON INGALLS INDUSTRIES, INC. | US4464131063 | Equity | 4,959 | +1,490 | 1.81% | $ 1.388M |
|
CSL LIMITED
|
AU000000CSL8 | Equity | 16,587 | +4,742 | 1.72% | $ 1.319M |
| NOVO NORDISK A/S | DK0062498333 | Equity | 27,346 | −4,148 | 1.72% | $ 1.316M |
|
Eisai Co., Ltd.
|
JP3160400002 | Equity | 51,200 | +12,000 | 1.69% | $ 1.298M |
| DEXCOM, INC. | US2521311074 | Equity | 19,178 | −1,508 | 1.69% | $ 1.292M |
| PALANTIR TECHNOLOGIES INC. | US69608A1088 | Equity | 11,012 | +1,433 | 1.68% | $ 1.285M |
|
Kyowa Kirin Co., Ltd.
|
JP3256000005 | Equity | 80,600 | −7,900 | 1.67% | $ 1.283M |
| CAMECO CORPORATION | CA13321L1085 | Equity | 12,556 | +1,890 | 1.67% | $ 1.279M |
| INTERCONTINENTAL HOTELS GROUP PLC | GB00BHJYC057 | Equity | 7,365 | −1,879 | 1.66% | $ 1.269M |
| Ferrovial N.V. | NL0015001FS8 | Equity | 18,475 | +410 | 1.65% | $ 1.267M |
| VERISIGN, INC. | US92343E1029 | Equity | 4,978 | −1,149 | 1.63% | $ 1.252M |
| BeOne Medicines AG | CH1391448177 | Equity | 57,500 | +3,800 | 1.63% | $ 1.249M |
|
Otsuka Holdings Co., Ltd.
|
JP3188220002 | Equity | 18,700 | −200 | 1.62% | $ 1.243M |
| SMITHS GROUP PLC | GB00B1WY2338 | Equity | 36,013 | +1,309 | 1.60% | $ 1.224M |
| Universal Music Group N.V. | NL0015000IY2 | Equity | 58,366 | +4,225 | 1.60% | $ 1.223M |
| BRITISH AMERICAN TOBACCO P.L.C. | GB0002875804 | Equity | 19,576 | −1,176 | 1.59% | $ 1.215M |
| Fresenius Medical Care AG | DE0005785802 | Equity | 26,832 | +377 | 1.59% | $ 1.215M |
| LEIDOS HOLDINGS, INC. | US5253271028 | Equity | 11,783 | +3,459 | 1.58% | $ 1.213M |
|
Astellas Pharma Inc.
|
JP3942400007 | Equity | 89,600 | +9,100 | 1.57% | $ 1.199M |
| EXPERIAN PLC | GB00B19NLV48 | Equity | 34,970 | +1,918 | 1.54% | $ 1.18M |
| BROOKFIELD ASSET MANAGEMENT LTD. | CA1130041058 | Equity | 26,118 | +323 | 1.53% | $ 1.171M |
| SINGAPORE TECHNOLOGIES ENGINEERING LTD | SG1F60858221 | Equity | 145,800 | +1,800 | 1.53% | $ 1.171M |
| BIOMERIEUX SA | FR0013280286 | Equity | 14,764 | +3,761 | 1.51% | $ 1.16M |
| Canadien Pacifique Kansas City Limitee | CA13646K1084 | Equity | 13,319 | −958 | 1.51% | $ 1.154M |
| EQT AB | SE0012853455 | Equity | 39,817 | +794 | 1.47% | $ 1.127M |
| SAAB Aktiebolag | SE0021921269 | Equity | 21,664 | +3,815 | 1.47% | $ 1.125M |
| SMITH & NEPHEW PLC | GB0009223206 | Equity | 77,020 | +7,295 | 1.46% | $ 1.115M |
| RELX PLC | GB00B2B0DG97 | Equity | 35,080 | +364 | 1.44% | $ 1.102M |
| FOX CORPORATION | US35137L1052 | Equity | 21,088 | −3,827 | 1.44% | $ 1.1M |
| SPOTIFY TECHNOLOGY S.A. | LU1778762911 | Equity | 2,376 | +178 | 1.42% | $ 1.091M |
| LyondellBasell Industries N.V. | NL0009434992 | Equity | 18,342 | −108 | 1.26% | $ 965.706K |
| SEZZLE INC. | US78435P1057 | Equity | 1,236 | new +1,236 | 0.28% | $ 212.135K |
| HIMS & HERS HEALTH, INC. | US4330001060 | Equity | 5,377 | −4,215 | 0.24% | $ 186.421K |
| REMITLY GLOBAL, INC. | US75960P1049 | Equity | 8,279 | new +8,279 | 0.24% | $ 185.532K |
| AAR CORP. | US0003611052 | Equity | 1,273 | −102 | 0.24% | $ 181.95K |
| IRIDIUM COMMUNICATIONS INC. | US46269C1027 | Equity | 3,275 | −3,066 | 0.23% | $ 179.634K |
| ACADIA PHARMACEUTICALS INC. | US0042251084 | Equity | 7,030 | +245 | 0.23% | $ 177.859K |
| SAREPTA THERAPEUTICS, INC. | US8036071004 | Equity | 9,886 | +505 | 0.23% | $ 177.651K |
| LATTICE SEMICONDUCTOR CORPORATION | US5184151042 | Equity | 1,129 | −542 | 0.23% | $ 172.692K |
| CORECIVIC, INC. | US21871N1019 | Equity | 5,648 | −2,619 | 0.22% | $ 171.586K |
| REYNOLDS CONSUMER PRODUCTS INC. | US76171L1061 | Equity | 6,372 | new +6,372 | 0.22% | $ 171.088K |
| SOLSTICE ADVANCED MATERIALS INC. | US83443Q1031 | Equity | 1,923 | new +1,923 | 0.22% | $ 170.378K |
| GLAUKOS CORPORATION | US3773221029 | Equity | 1,219 | new +1,219 | 0.22% | $ 170.367K |
| FLUOR CORPORATION. | US3434121022 | Equity | 3,189 | −107 | 0.22% | $ 167.072K |
| InterDigital, Inc. | US45867G1013 | Equity | 588 | +170 | 0.22% | $ 166.48K |
| PTC THERAPEUTICS, INC. | US69366J2006 | Equity | 2,036 | new +2,036 | 0.22% | $ 166.077K |
| LANTHEUS HOLDINGS, INC. | US5165441032 | Equity | 1,491 | −502 | 0.22% | $ 165.412K |
| ETSY, INC. | US29786A1060 | Equity | 2,174 | −512 | 0.21% | $ 163.767K |
| Arlo Technologies Inc | US04206A1016 | Equity | 12,123 | +1,442 | 0.21% | $ 163.418K |
| PACIRA BIOSCIENCES, INC. | US6951271005 | Equity | 6,385 | new +6,385 | 0.21% | $ 161.987K |
| ILLUMINA, INC. | US4523271090 | Equity | 920 | −268 | 0.21% | $ 161.764K |
| INDIVIOR PHARMACEUTICALS, INC. | US45579U1097 | Equity | 3,920 | new +3,920 | 0.21% | $ 160.838K |
| UNIVERSAL TECHNICAL INSTITUTE, INC. | US9139151040 | Equity | 3,758 | new +3,758 | 0.21% | $ 160.73K |
| CHEMED CORPORATION | US16359R1032 | Equity | 344 | −26 | 0.21% | $ 160.215K |
| SOLAREDGE TECHNOLOGIES, INC. | US83417M1045 | Equity | 2,738 | −1,300 | 0.21% | $ 160.009K |
| THE GEO GROUP, INC. | US36162J1060 | Equity | 5,308 | −4,882 | 0.20% | $ 156.851K |
| NEUROCRINE BIOSCIENCES, INC. | US64125C1099 | Equity | 929 | −243 | 0.20% | $ 156.569K |
| UL SOLUTIONS INC. | US9037311076 | Equity | 1,533 | new +1,533 | 0.20% | $ 156.151K |
| PITNEY BOWES INC. | US7244791007 | Equity | 8,834 | −5,125 | 0.20% | $ 154.772K |
| EXELIXIS, INC. | US30161Q1040 | Equity | 2,841 | −842 | 0.20% | $ 154.579K |
| NEXSTAR MEDIA GROUP, INC. | US65336K1034 | Equity | 861 | +261 | 0.20% | $ 153.766K |
| POLARIS INC. | US7310681025 | Equity | 2,246 | −542 | 0.20% | $ 153.716K |
| HARMONY BIOSCIENCES HOLDINGS, INC. | US4131971040 | Equity | 4,210 | −1,130 | 0.20% | $ 153.286K |
| H & R BLOCK, INC. | US0936711052 | Equity | 4,015 | −783 | 0.20% | $ 152.891K |
| THE CHEMOURS COMPANY | US1638511089 | Equity | 7,355 | −1,741 | 0.20% | $ 150.925K |
| YELP INC. | US9858171054 | Equity | 6,152 | −111 | 0.20% | $ 150.847K |
| KBR, INC. | US48242W1062 | Equity | 4,364 | new +4,364 | 0.20% | $ 150.689K |
| PHIBRO ANIMAL HEALTH CORPORATION | US71742Q1067 | Equity | 4,790 | +1,725 | 0.20% | $ 150.406K |
| HEALTHEQUITY, INC. | US42226A1079 | Equity | 1,665 | −236 | 0.20% | $ 150.383K |
| LIVERAMP HOLDINGS, INC. | US53815P1084 | Equity | 3,966 | −1,232 | 0.19% | $ 149.28K |
|
SELECT MEDICAL HOLDINGS CORP
|
US81619Q1058 | Equity | 8,998 | −368 | 0.19% | $ 148.557K |
| DROPBOX, INC. | US26210C1045 | Equity | 5,403 | −359 | 0.19% | $ 148.42K |
| SCIENCE APPLICATIONS INTERNATIONAL CORPORATION | US8086251076 | Equity | 1,308 | −320 | 0.19% | $ 144.416K |
| COVISTA INC. | US00737L1035 | Equity | 1,147 | −344 | 0.19% | $ 142.985K |
| SYLVAMO CORPORATION | US8713321029 | Equity | 3,755 | +384 | 0.19% | $ 141.939K |
| PARSONS CORPORATION | US70202L1026 | Equity | 2,645 | +323 | 0.18% | $ 138.572K |
| GOGO INC. | US38046C1099 | Equity | 43,931 | new +43,931 | 0.18% | $ 136.186K |
| PERDOCEO EDUCATION CORPORATION | US71363P1066 | Equity | 4,241 | −186 | 0.18% | $ 135.712K |
| MAXIMUS, INC. | US5779331041 | Equity | 2,435 | +504 | 0.17% | $ 130.906K |
| STRIDE, INC. | US86333M1080 | Equity | 1,497 | −265 | 0.17% | $ 129.101K |
| BOOZ ALLEN HAMILTON HOLDING CORPORATION | US0995021062 | Equity | 1,932 | new +1,932 | 0.15% | $ 117.214K |
Trades Mar 31, 2026 to Jun 30, 2026
Changes in shares between the fund's two newest published portfolios, cash left out. Value is the change at the line's own price in the newer portfolio.
| Holding | Ticker | Action | Before | After | Change | Value |
|---|---|---|---|---|---|---|
| CIENA CORPORATION | New | — | 3,299 | +3,299 | $ 1.618M | |
| CHIPOTLE MEXICAN GRILL, INC. | New | — | 47,137 | +47,137 | $ 1.603M | |
| BIOGEN INC. | New | — | 7,383 | +7,383 | $ 1.595M | |
| HUMANA INC. | New | — | 3,935 | +3,935 | $ 1.563M | |
| LABCORP HOLDINGS INC. | New | — | 5,338 | +5,338 | $ 1.495M | |
| GILEAD SCIENCES, INC. | New | — | 11,803 | +11,803 | $ 1.491M | |
| INSULET CORPORATION | New | — | 9,515 | +9,515 | $ 1.449M | |
| YUM! Brands, Inc. | Closed | 9,229 | — | −9,229 | $ -1.435M | |
| MATCH GROUP, INC. | Closed | 46,714 | — | −46,714 | $ -1.435M | |
| EBAY INC. | Closed | 15,724 | — | −15,724 | $ -1.431M | |
| CF INDUSTRIES HOLDINGS, INC. | New | — | 13,123 | +13,123 | $ 1.421M | |
| VERTEX PHARMACEUTICALS INCORPORATED | Closed | 3,175 | — | −3,175 | $ -1.418M | |
| HONEYWELL INTERNATIONAL INCORPORATION | Closed | 6,141 | — | −6,141 | $ -1.388M | |
| Northrop Grumman Corporation | Closed | 1,977 | — | −1,977 | $ -1.349M | |
| EQUIFAX INC. | Closed | 7,074 | — | −7,074 | $ -1.274M | |
| PARAMOUNT SKYDANCE CORPORATION | Closed | 124,560 | — | −124,560 | $ -1.124M | |
| DAVITA INC. | Sold | 9,747 | 7,223 | −2,524 | $ -561.54K | |
| HUNTINGTON INGALLS INDUSTRIES, INC. | Bought | 3,469 | 4,959 | +1,490 | $ 417.036K | |
|
CSL LIMITED
|
Bought | 11,845 | 16,587 | +4,742 | $ 376.95K | |
| AXON ENTERPRISE, INC. | Bought | 2,564 | 3,203 | +639 | $ 358.23K | |
| LEIDOS HOLDINGS, INC. | Bought | 8,324 | 11,783 | +3,459 | $ 356.173K | |
| INTERCONTINENTAL HOTELS GROUP PLC | Sold | 9,244 | 7,365 | −1,879 | $ -323.658K | |
| TERADYNE, INC. | Sold | 4,787 | 4,126 | −661 | $ -319.818K | |
|
Eisai Co., Ltd.
|
Bought | 39,200 | 51,200 | +12,000 | $ 304.126K | |
| A. O. SMITH CORPORATION | Bought | 20,306 | 25,059 | +4,753 | $ 298.108K | |
| BIOMERIEUX SA | Bought | 11,003 | 14,764 | +3,761 | $ 295.407K | |
| VERISIGN, INC. | Sold | 6,127 | 4,978 | −1,149 | $ -289.042K | |
| LOCKHEED MARTIN CORPORATION | Bought | 2,234 | 2,731 | +497 | $ 253.202K | |
| FAIR ISAAC CORPORATION | Bought | 991 | 1,175 | +184 | $ 219.84K | |
| SEZZLE INC. | New | — | 1,236 | +1,236 | $ 212.135K | |
| FOX CORPORATION | Sold | 24,915 | 21,088 | −3,827 | $ -199.616K | |
| NOVO NORDISK A/S | Sold | 31,494 | 27,346 | −4,148 | $ -199.596K | |
| SAAB Aktiebolag | Bought | 17,849 | 21,664 | +3,815 | $ 198.197K | |
| CAMECO CORPORATION | Bought | 10,666 | 12,556 | +1,890 | $ 192.577K | |
| REMITLY GLOBAL, INC. | New | — | 8,279 | +8,279 | $ 185.532K | |
| CORE NATURAL RESOURCES, INC. | Closed | 1,711 | — | −1,711 | $ -179.193K | |
| REYNOLDS CONSUMER PRODUCTS INC. | New | — | 6,372 | +6,372 | $ 171.088K | |
| SOLSTICE ADVANCED MATERIALS INC. | New | — | 1,923 | +1,923 | $ 170.378K | |
| GLAUKOS CORPORATION | New | — | 1,219 | +1,219 | $ 170.367K | |
| IRIDIUM COMMUNICATIONS INC. | Sold | 6,341 | 3,275 | −3,066 | $ -168.17K | |
| PALANTIR TECHNOLOGIES INC. | Bought | 9,579 | 11,012 | +1,433 | $ 167.188K | |
| PTC THERAPEUTICS, INC. | New | — | 2,036 | +2,036 | $ 166.077K | |
| CENTURY ALUMINUM COMPANY | Closed | 2,825 | — | −2,825 | $ -165.799K | |
| INCYTE CORPORATION | Sold | 15,036 | 13,606 | −1,430 | $ -162.105K | |
| PACIRA BIOSCIENCES, INC. | New | — | 6,385 | +6,385 | $ 161.987K | |
| INGEVITY CORPORATION | Closed | 2,267 | — | −2,267 | $ -161.478K | |
| INDIVIOR PHARMACEUTICALS, INC. | New | — | 3,920 | +3,920 | $ 160.838K | |
| UNIVERSAL TECHNICAL INSTITUTE, INC. | New | — | 3,758 | +3,758 | $ 160.73K | |
| BRISTOW GROUP INC. | Closed | 3,414 | — | −3,414 | $ -160.082K | |
| Altria Group, Inc. | Sold | 21,812 | 19,608 | −2,204 | $ -158.578K | |
| SUNCOKE ENERGY, INC. | Closed | 24,255 | — | −24,255 | $ -157.9K | |
| GRAND CANYON EDUCATION, INC. | Closed | 923 | — | −923 | $ -156.938K | |
| UL SOLUTIONS INC. | New | — | 1,533 | +1,533 | $ 156.151K | |
| Koppers Holdings Inc. | Closed | 3,998 | — | −3,998 | $ -154.643K | |
| KBR, INC. | New | — | 4,364 | +4,364 | $ 150.689K | |
| MATERION CORPORATION | Closed | 1,012 | — | −1,012 | $ -146.386K | |
| HIMS & HERS HEALTH, INC. | Sold | 9,592 | 5,377 | −4,215 | $ -146.134K | |
| AMNEAL PHARMACEUTICALS, INC. | Closed | 11,699 | — | −11,699 | $ -145.419K | |
| THE GEO GROUP, INC. | Sold | 10,190 | 5,308 | −4,882 | $ -144.263K | |
| HEXCEL CORPORATION | Closed | 1,705 | — | −1,705 | $ -137.986K | |
| GOGO INC. | New | — | 43,931 | +43,931 | $ 136.186K | |
| MYRIAD GENETICS, INC. | Closed | 29,645 | — | −29,645 | $ -133.403K | |
|
Kyowa Kirin Co., Ltd.
|
Sold | 88,500 | 80,600 | −7,900 | $ -125.749K | |
| KRATOS DEFENSE & SECURITY SOLUTIONS, INC. | Closed | 1,779 | — | −1,779 | $ -125.437K | |
|
Astellas Pharma Inc.
|
Bought | 80,500 | 89,600 | +9,100 | $ 121.781K | |
| BOOZ ALLEN HAMILTON HOLDING CORPORATION | New | — | 1,932 | +1,932 | $ 117.214K | |
| TRANSMEDICS GROUP, INC. | Closed | 1,086 | — | −1,086 | $ -107.959K | |
| SMITH & NEPHEW PLC | Bought | 69,725 | 77,020 | +7,295 | $ 105.585K | |
| DEXCOM, INC. | Sold | 20,686 | 19,178 | −1,508 | $ -101.564K | |
| PITNEY BOWES INC. | Sold | 13,959 | 8,834 | −5,125 | $ -89.79K | |
| Universal Music Group N.V. | Bought | 54,141 | 58,366 | +4,225 | $ 88.542K | |
| Canadien Pacifique Kansas City Limitee | Sold | 14,277 | 13,319 | −958 | $ -83.028K | |
| LATTICE SEMICONDUCTOR CORPORATION | Sold | 1,671 | 1,129 | −542 | $ -82.904K | |
| BeOne Medicines AG | Bought | 53,700 | 57,500 | +3,800 | $ 82.57K | |
| SPOTIFY TECHNOLOGY S.A. | Bought | 2,198 | 2,376 | +178 | $ 81.725K | |
| CORECIVIC, INC. | Sold | 8,267 | 5,648 | −2,619 | $ -79.565K | |
| SOLAREDGE TECHNOLOGIES, INC. | Sold | 4,038 | 2,738 | −1,300 | $ -75.972K | |
| BRITISH AMERICAN TOBACCO P.L.C. | Sold | 20,752 | 19,576 | −1,176 | $ -73.001K | |
| EXPERIAN PLC | Bought | 33,052 | 34,970 | +1,918 | $ 64.736K | |
| LANTHEUS HOLDINGS, INC. | Sold | 1,993 | 1,491 | −502 | $ -55.692K | |
| PHIBRO ANIMAL HEALTH CORPORATION | Bought | 3,065 | 4,790 | +1,725 | $ 54.165K | |
| GENERAL DYNAMICS CORPORATION | Bought | 4,054 | 4,205 | +151 | $ 53.49K | |
| TEXTRON INC. | Bought | 15,171 | 15,701 | +530 | $ 48.617K | |
| InterDigital, Inc. | Bought | 418 | 588 | +170 | $ 48.132K | |
| ILLUMINA, INC. | Sold | 1,188 | 920 | −268 | $ -47.122K | |
| NEXSTAR MEDIA GROUP, INC. | Bought | 600 | 861 | +261 | $ 46.612K | |
| LIVERAMP HOLDINGS, INC. | Sold | 5,198 | 3,966 | −1,232 | $ -46.372K | |
| EXELIXIS, INC. | Sold | 3,683 | 2,841 | −842 | $ -45.813K | |
| SMITHS GROUP PLC | Bought | 34,704 | 36,013 | +1,309 | $ 44.477K | |
| COVISTA INC. | Sold | 1,491 | 1,147 | −344 | $ -42.883K | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Sold | 5,340 | 4,210 | −1,130 | $ -41.143K | |
| NEUROCRINE BIOSCIENCES, INC. | Sold | 1,172 | 929 | −243 | $ -40.954K | |
| ETSY, INC. | Sold | 2,686 | 2,174 | −512 | $ -38.569K | |
| POLARIS INC. | Sold | 2,788 | 2,246 | −542 | $ -37.094K | |
| THE CHEMOURS COMPANY | Sold | 9,096 | 7,355 | −1,741 | $ -35.725K | |
| SCIENCE APPLICATIONS INTERNATIONAL CORPORATION | Sold | 1,628 | 1,308 | −320 | $ -35.331K | |
| H & R BLOCK, INC. | Sold | 4,798 | 4,015 | −783 | $ -29.817K | |
| Ferrovial N.V. | Bought | 18,065 | 18,475 | +410 | $ 28.116K | |
| MAXIMUS, INC. | Bought | 1,931 | 2,435 | +504 | $ 27.095K | |
| STANLEY BLACK & DECKER, INC. | Sold | 18,781 | 18,510 | −271 | $ -25.507K | |
| STRIDE, INC. | Sold | 1,762 | 1,497 | −265 | $ -22.854K | |
| EQT AB | Bought | 39,023 | 39,817 | +794 | $ 22.479K | |
| HEALTHEQUITY, INC. | Sold | 1,901 | 1,665 | −236 | $ -21.316K | |
| Arlo Technologies Inc | Bought | 10,681 | 12,123 | +1,442 | $ 19.438K | |
| Fresenius Medical Care AG | Bought | 26,455 | 26,832 | +377 | $ 17.069K | |
| PARSONS CORPORATION | Bought | 2,322 | 2,645 | +323 | $ 16.922K | |
| AAR CORP. | Sold | 1,375 | 1,273 | −102 | $ -14.579K | |
| SYLVAMO CORPORATION | Bought | 3,371 | 3,755 | +384 | $ 14.515K | |
| BROOKFIELD ASSET MANAGEMENT LTD. | Bought | 25,795 | 26,118 | +323 | $ 14.484K | |
| SINGAPORE TECHNOLOGIES ENGINEERING LTD | Bought | 144,000 | 145,800 | +1,800 | $ 14.459K | |
|
Otsuka Holdings Co., Ltd.
|
Sold | 18,900 | 18,700 | −200 | $ -13.296K | |
| CHEMED CORPORATION | Sold | 370 | 344 | −26 | $ -12.109K | |
| RELX PLC | Bought | 34,716 | 35,080 | +364 | $ 11.431K | |
| DROPBOX, INC. | Sold | 5,762 | 5,403 | −359 | $ -9,861.73 | |
| SAREPTA THERAPEUTICS, INC. | Bought | 9,381 | 9,886 | +505 | $ 9,074.85 | |
| ACADIA PHARMACEUTICALS INC. | Bought | 6,785 | 7,030 | +245 | $ 6,198.50 | |
|
SELECT MEDICAL HOLDINGS CORP
|
Sold | 9,366 | 8,998 | −368 | $ -6,075.68 | |
| PERDOCEO EDUCATION CORPORATION | Sold | 4,427 | 4,241 | −186 | $ -5,952.00 | |
| LyondellBasell Industries N.V. | Sold | 18,450 | 18,342 | −108 | $ -5,686.20 | |
| FLUOR CORPORATION. | Sold | 3,296 | 3,189 | −107 | $ -5,605.73 | |
| YELP INC. | Sold | 6,263 | 6,152 | −111 | $ -2,721.72 | |
|
BROWN BROTHERS HARRIMAN & CO. FX Forward Contract: USD/JPY SETTLE 2026-04-01
|
Closed | 1 | — | −1 | $ 29.15 |
Podcast Mentions
Sign up to see podcast mentions and sentiment
Sign Up